Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis.
about
Intravenous immunoglobulin for presumed viral myocarditis in children and adultsIntravenous immunoglobulin for presumed viral myocarditis in children and adultsA systematic review of intravenous gamma globulin for therapy of acute myocarditis.Veno-arterial extracorporeal membrane oxygenation for cardiogenic shock due to myocarditis in adult patientsInflammatory Cardiomyopathy: A Current View on the Pathophysiology, Diagnosis, and TreatmentTemporary mechanical circulatory support: a review of the options, indications, and outcomesRapid Extracorporeal Membrane Oxygenation Overcomes Fulminant Myocarditis Induced by 5‑Fluorouracil.Acute viral myocarditis2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of theClinical Outcomes in Pediatric Patients Hospitalized with Fulminant Myocarditis Requiring Extracorporeal Membrane Oxygenation: A Meta-analysis.[102 patients with suspected myocarditis : Clinical presentation, diagnostics, therapy and prognosis].Influenza B-induced refractory cardiogenic shock: a case report.Factors and values at admission that predict a fulminant course of acute myocarditis: data from Tokyo CCU network database.Biventricular assist device placement and immunosuppression as therapy for necrotizing eosinophilic myocarditis.Proteomic analysis reveals virus-specific Hsp25 modulation in cardiac myocytes.Rapid Resolution of Acute Fulminant Myocarditis after IVIG and Steroid TreatmentIncreased risk of ventricular tachycardia and cardiovascular death in patients with myocarditis during the long-term follow-up: A national representative cohort from the National Health Insurance Research Database.Parvovirus B19-induced vascular damage in the heart is associated with elevated circulating endothelial microparticles.Active lymphocytic myocarditis treated with murine OKT3 monoclonal antibody in a patient presenting with intractable ventricular tachycardia.Histopathological diagnosis of myocarditis in a dengue outbreak in Sri Lanka, 2009.Myocarditis, pericarditis and other pericardial diseasesProteomic and biochemical analyses reveal the activation of unfolded protein response, ERK-1/2 and ribosomal protein S6 signaling in experimental autoimmune myocarditis rat modelAcute viral myocarditis: role of immunosuppression: a prospective randomised study.The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a reviewAntiphospholipid syndrome; its implication in cardiovascular diseases: a review.Mechanical circulatory support with the ABIOMED BVS 5000: the Toronto General Hospital experience.The group B coxsackieviruses and myocarditis.Animal models of cardiac disease and stem cell therapy.Heart failure in the young.Extracorporeal membrane oxygenation for the support of infants, children, and young adults with acute myocarditis: a review of the Extracorporeal Life Support Organization registry.Clinical features and short-term outcomes of pediatric acute fulminant myocarditis in a single centerSupport with the BVS 5000 assist device during treatment of acute giant-cell myocarditisMyocarditis, disseminated infection, and early viral persistence following experimental coxsackievirus B infection of cynomolgus monkeysPediatric cardiac emergencies: Children are not small adultsFatal fulminant myocarditis caused by disseminated mucormycosisImmunomodulatory treatment strategies in inflammatory cardiomyopathy: current status and future perspectives.Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype.Outcome of acute fulminant myocarditis in children.Potential of the right ventricular endomyocardial biopsy to diagnose and assist in the management of congestive heart failure: insights from recent clinical trials.The TandemHeart pVAD in the treatment of acute fulminant myocarditis.
P2860
Q24187897-7BF4EEB4-5D5A-4A44-80EA-62B29EE0FDD6Q24244970-2E204721-F53F-4D08-BA40-AA494A9DE17CQ24815545-FBFDC0F7-33F4-4E55-A7D6-F1E4B4FB2349Q26738599-2DFD8E10-53B4-4F6D-8A9B-EFAF010699A9Q26744257-37CDA29C-1974-43AB-8E23-47FBF23061A3Q26824537-744C991C-8A35-49D6-86B6-DBF0154F0715Q27348720-C7E77AE7-6970-4EF4-8FF6-5C86AB8E2057Q27486698-472B68BD-4EB6-496D-9726-14FAB5DC6CC2Q28087002-774843A4-1F42-493B-9199-C8C6B192D7FEQ30240773-7F635011-EC01-4206-974F-82E8C1A1B78EQ30313532-863C71E2-B942-4840-99D7-924807FF25B8Q30354032-6E1622EE-2675-4E38-8943-8CBD146812C4Q31170147-A7DC9E52-A46F-4982-A938-830C342045DEQ33153109-981931FB-EBEC-4C52-94C9-61BD0EDD187EQ33536101-95225087-95ED-4AEE-B719-49C1798CFC29Q33566037-B216DA71-C6C9-4332-B7B8-1E1479B05C02Q33644095-88F99437-F2EC-4DF1-9748-5F45B230BD8FQ33712962-15806C2B-FB60-4015-8017-3DECF70B063AQ33881168-5766A777-9BC4-4E18-956F-3B5E8D97E8B8Q33974343-E7D9DF1E-BA23-47E7-B9C5-5FEB0EAF3ED7Q34038006-A90CCBC6-B260-4208-83B9-530415FAAE97Q34052465-E2B9280F-9D90-4DAC-91BF-503FB5708C9AQ34123116-2ADD68C6-5C27-4D82-88CB-B82B0B5EED2FQ34219414-E0E6FD40-90E3-4CC4-B2AE-55C653525AFEQ34331685-A8AF8173-3D2F-41B8-B339-D68150A222FDQ34338629-E24C29F4-F94B-44FE-AAC2-7AE287565337Q34464947-8918D7EC-34C0-4F4A-9BA7-D9331898EF7CQ34508351-1BF77690-1B1A-47BD-9A2A-14C34349B9A3Q34739129-38EE8F01-D794-4F8D-BE98-4DDAA3798E3DQ34754236-090998A8-39F4-47F8-AD76-59D9178A6742Q34785271-160A0054-C4DE-4C39-9D8F-6EA73C95AB04Q34907735-8307E057-9AAE-4902-AB93-69DFC36B4D9BQ34990152-E042CDAF-BCE3-40CF-A9E0-3465FB1BA305Q34991282-E6F3FECE-0775-42D1-9574-D0954E2F7C56Q35582917-DACBA357-15A1-410D-8C81-ED602AA25A9FQ35706837-8256731E-533A-4D56-B147-2E2309FD2189Q35746595-F246868A-9A61-4082-ADD6-0DE25B79EA65Q35772432-D2AAA616-368F-4460-B865-158B612AE207Q35796780-FC169A0D-69BF-4023-8826-4CB8D88FC7DAQ35846601-3504E105-CD2C-4015-87A1-BCA2AF99BD3E
P2860
Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Long-term outcome of fulminant ...... te (nonfulminant) myocarditis.
@en
type
label
Long-term outcome of fulminant ...... te (nonfulminant) myocarditis.
@en
prefLabel
Long-term outcome of fulminant ...... te (nonfulminant) myocarditis.
@en
P2093
P1476
Long-term outcome of fulminant ...... te (nonfulminant) myocarditis.
@en
P2093
Baughman KL
Boehmer JP
Hutchins GM
McCarthy RE 3rd
P304
P356
10.1056/NEJM200003093421003
P407
P577
2000-03-01T00:00:00Z